Rosuvastatin

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Rosuvastatin and local guidelines before prescribing.

Statin

Mechanism

HMG-CoA reductase inhibitor.

Uses

Hypercholesterolaemia, cardiovascular prevention.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Myalgia, raised ALT, proteinuria at high dose, new-onset diabetes.

Interactions

Ciclosporin, gemfibrozil raise levels; warfarin effect increased.

Contraindications and cautions

Active liver disease, severe renal impairment (higher doses)

Monitoring

Lipids, ALT, CK if symptoms

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

Reduce dose in renal impairment

Overdose and reversal

Supportive

Special advice

Lower dose in Asian patients and renal impairment; check CK if muscle symptoms.

More from the textbook: uses, cautions and other points
Where it is discussed in the book